Skip to main content
Premium Trial:

Request an Annual Quote

Bruker, Chungnam National University Partner on Glycan Analysis

NEW YORK (GenomeWeb News) – Bruker and Chungnam National University in South Korea announced today a collaboration to develop MALDI-TOF-based methodologies for the analysis of glycans.

The deal between Bruker and the Graduate School of Analytical Science and Technology at the university will be targeted mainly at creating methods and software applications in the development and quality control of biologics, such as therapeutic antibodies, they said.

The partnership will also serve as an Asia Glycomics Reference Site and provide support to the wider Asian Glycomics community, they added. The work is expected to "create a better understanding of the function of glycans in biomolecules and their key role in many biological processes."

Financial and other terms of the deal were not disclosed.

The research will be led by Hyun Joo An, a professor at the university, and Detlev Suckau at Bruker.

"The potential we see, particularly for the biosimilar industry, indicates that glycan research will continue to increase in importance, particularly as workflows develop to unravel its complexities," An said in a statement.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.